Compounds > 2,3-bis(3'-hydroxybenzyl)butyrolactone
Page last updated: 2024-09-02

2,3-bis(3'-hydroxybenzyl)butyrolactone and trimethyloxamine

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with trimethyloxamine in 1 studies

Compound Research Comparison

Studies
(2,3-bis(3'-hydroxybenzyl)butyrolactone)		Trials
(2,3-bis(3'-hydroxybenzyl)butyrolactone)		Recent Studies (post-2010)
(2,3-bis(3'-hydroxybenzyl)butyrolactone)		Studies
(trimethyloxamine)		Trials
(trimethyloxamine)		Recent Studies (post-2010) (trimethyloxamine)
319321241,573751,161

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chan, AT; Franke, AA; Hu, FB; Hu, Y; Li, J; Li, Y; Liang, L; Liu, G; Mukamal, KJ; Rimm, EB; Sun, Q1

Other Studies

1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and trimethyloxamine

ArticleYear
Gut microbiota-derived metabolites and risk of coronary artery disease: a prospective study among US men and women.
    The American journal of clinical nutrition, 2021, 07-01, Volume: 114, Issue:1

    Topics: 4-Butyrolactone; Adult; Case-Control Studies; Coronary Disease; Diet; Female; Gastrointestinal Microbiome; Humans; Lignans; Male; Methylamines; Prospective Studies; Risk Factors; United States

2021